BeOne Medicines
Gina Kassabian currently serves as Associate Director of Global Regulatory Operations at BeiGene since June 2023, following a 12-year tenure at Amgen where roles included Sr. Manager of Global Regulatory Operations - Data Management and Manager of GRAAS Operations, focusing on process management and serving as a subject matter expert and trainer for the Veeva Vault Regulatory Information Management system. Prior experience encompasses positions at Telcordia Technologies, Kurz-Kasch, Inc., InterGlobal Waste Management, Inc., and Medical Analysis Systems, Inc., where responsibilities ranged from operational support to regulatory analysis. Gina Kassabian's education includes studies at DeVry University and Indiana University Kokomo.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.